MSH2 and ovarian carcinoma: Song et al. have performed this type of analysis in 131 predicted deleterious missense variants in BRCA1/2 and the MMR genes (MLH1, MSH2, MSH6, and PMS2) and found little evidence for ovarian cancer risk association between these variants in any of the six genes [33].